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ABSTRACT
The pathogenic bacterium Group A Streptococcus
pyogenes produces several extracellular DNases
that have been shown to facilitate invasive infection
by evading the human host immune system. DNases
degrade the chromatin in neutrophil extracellular
traps, enabling the bacterium to evade neutrophil
capture. Spd1 is a type I, nonspecific bba/metal-
dependent nuclease from Streptococcus
pyogenes, which is encoded by the SF370.1
prophage and is likely to be expressed as a result
of prophage induction. We present here the X-ray
structure of this DNase in the wild-type and
Asn145Ala mutant form. Through structural and
sequence alignments as well as mutagenesis
studies, we have identified the key residues
His121, Asn145 and Glu164, which are crucial for
Spd1 nucleolytic activity and shown the active site
constellation. Our wild-type structure alludes to
the possibility of a catalytically blocked dimeric
form of the protein. We have investigated the
multimeric nature of Spd1 using size-exclusion
chromatography with multi-angle light scattering
(SEC-MALLS) in the presence and absence of the
divalent metal ion Mg
2+, which suggests that Spd1
exists in a monomeric form in solution.
INTRODUCTION
Non-speciﬁc nucleases play broad biological roles in
various cellular processes, such as scavenging of nucleo-
tides and phosphates for cell growth, DNA repair and
recombination, DNA fragmentation during apoptosis,
host defence against bacterial invasion and notably estab-
lishment of infection (1). The human pathogen Group A
Streptococcus pyogenes M1 (GAS) uses extracellular
DNases to establish infection by degrading the DNA in
neutrophil extracellular traps (NETs) (2). NETs are
web-like DNA structures, built from chromatin, proteases
and antimicrobial peptides that entrap and kill pathogenic
bacteria (3). The DNase activity destroys the NETs and
enables the S. pyogenes to adopt a more invasive and ag-
gressive mode of growth, which may ultimately lead to
life-threatening manifestations of streptococcal infection,
such as necrotizing fasciitis (4).
It was not until the era of genomic sequencing that the
degree of phage involvement in the transfer and regulation
of streptococcal virulence factors was fully appreciated
(5,6). In the S. pyogenes strain SF370,  10% of the
genome was found to be prophage-encoded, making up
four complete or partially integrated sequences (SF370.1,
370.2, 370.3 and 370.4) (7). Spd1 [formerly known as mito-
genic factor 2 (MF2), streptodornase and DNase C (8)] is
a type I extracellular DNase expressed by an inducible
prophage SF370.1 Spd1 is a 28KDa protein which
possesses an N-terminal signal peptide, cleaved during
extracellular secretion. It has an interesting genomic
location, being situated adjacent to the SpeC toxin gene
(Scarlatina toxin) (9). Spd1 and SpeC co-expression is
likely to occur as a result of prophage induction. This
has been demonstrated in the related CS112 strain
(8,10), where after addition of soluble phage inducing
factor (SPIF) secreted from pharyngeal cells, several viru-
lence factors were induced (8,10). Another study on 568
emm28 GAS strains isolated from invasive and pharyn-
gitis cases identiﬁed 29 distinct phage encoded virulence
genes. Eighty-four percent of these strains contained both
the Spd1 and SpeC toxin genes, making this pair quanti-
tatively highly important (11). Other bioinformatic and
phylogenetic evidence points to a recombination basis
for this observation. This may be in part due to the
frequent association of a so-called ‘paratox’ open
reading frame adjacent to these virulence genes (12).
Structure
The main structural characteristic of this class of DNase is
the presence of a bba-metal (bba-Me) ﬁnger motif (13).
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been determined include: the site-speciﬁc homing endo-
nuclease I-PpoI from Physarum polycephanum (14), the
non-speciﬁc nuclease Sm from Serratia marcenscens (15),
the Escherichia coli colicin E7 (ColE7) (16), the phage T4
endonuclease VII (17), the homing endonuclease I-HmuI
(18), the non-speciﬁc endonuclease from Anabaena sp.
(19), the Vibrio vulniﬁcus endonuclease Vvn (20), an extra-
cellular endonuclease VcEndA from Vibrio cholerae (21),
the caspase-activated DNase CAD (22) and the EndA
nuclease from Streptococcus pneumoniae (23). These
proteins are structurally highly diverse, but all display a
bba-Me motif. The bba-Me topology is comprised of two
anti-parallel b-strands and an a-helix with a centrally
located divalent metal ion. This bba-Me contains the
key residues essential for catalysis.
Here, we present the crystal structures of Spd1 DNase
wild-type (WT) at 1.7A ˚ resolution and that of a Spd1
Asn145Ala mutant at 2.5A ˚ resolution. Structural
analysis conﬁrms Spd1 belongs to the bba-metal ﬁnger
nucleases, with a conserved RGH active site sequence
motif. Mutagenesis studies and structure comparisons of
Spd1 with other bba-metal nucleases identify catalytically
important residues and infer a DNA hydrolysis mechan-
ism. The crystal structure of Spd1 Asn145Ala highlights
the importance of Asn145 in the active site metal ion co-
ordination and maintenance of activity.
EXPERIMENTAL PROCEDURES
Cloning, expression and puriﬁcation
The Spd1 gene (NCBI ID: NC_002737.1) was ampliﬁed
from S. pyogenes M1 SF370 (ATCC 700294) genomic
DNA template and annealed into the pET-YSBLIC
vector (24). Escherichia coli BL21 (DE3)-RIPL was trans-
formed with the native Spd1 gene and expressed in the
autoinduction media at 20 C for 18h (25). Cultures were
harvested and lysed using a high-pressure cell disruptor.
Cell debris was separated from soluble fraction by centri-
fugation at 48000g. The Spd1 protein was puriﬁed by
nickel-afﬁnity chromatography, followed by anion
exchange (MonoQ, GE Healthcare) and gel ﬁltration
chromatography. Pure protein sample was concentrated
to 26mgml
 1 in 25mM Tris/HCl pH 7.5 and used in
crystallization trials. Selenomethionine-labelled protein
was produced in E. coli B834 (DE3) cells, in
PASM-5052 Se-Met-labelling auto-induction media (25).
SeMet Spd1 was puriﬁed following the protocol for the
native protein.
Point mutations of the active site residues were
introduced using Stratagene QuikChange site-directed
mutagenesis kit. Fourteen mutants (Asp88Ala, Arg90Ala,
Lys92Ala, Asn118Ala, Arg119Ala, His121Ala, His121Asp,
His121Asn, Gln126Ala, Met140Ala, Asn145Ala,
Asn145Gln, Glu164Ala and Asn165Ala) were produced
(see Supplementary Table S1 for primer sequences). The
constructs were expressed and puriﬁed on a small-scale
format. Brieﬂy, the plasmids were transformed into
E. coli BL21 (DE3) strain and grown in 50ml of LB
media until OD600 reached 0.6–0.8. After that cultures
were induced with IPTG and grown for another
3.5h. Cellular pellets were harvested by centrifugation
and resuspended in 1ml of BugBuster Protein
Extraction Reagent (Merck) and incubated for 30min
on ice. Cell suspensions were spun down and loaded
onto disposable Ni-NTA Spin columns (Qiagen). WT
Spd1 was included as positive control and cells trans-
formed with empty pET-YSBLIC vector were used as a
negative control.
Crystallization and data collection
The Spd1 crystals were grown in 24-well Linbro
plates using a hanging drop vapour diffusion method. A
total of 0.5ml of the protein was mixed with 0.5mlo f
the mother liquor, containing 0.2M sodium citrate,
0.1M bis–Tris propane 7.5 and 20% PEG 3350.
Selenomethionine-derivative crystals grew in a 96-well
MRC crystallization Plate
TM (Molecular Dimensions
Ltd) set-up by Mosquito Nanodrop crystallization robot
(Molecular Dimensions Ltd). A total of 100nl of the
protein was mixed in 1:1 ratio with the reservoir
solution, containing Malic/MES/Tris system pH 6.0 and
25% PEG 1.5K. The crystals were cryoprotected in the
mother liquor solution by the addition of 25% glycerol,
vitriﬁed in liquid nitrogen and tested for diffraction. The
native crystal diffraction data were collected to 1.7A ˚ at
the ESRF, Grenoble on beamline ID14-1 at a temperature
of 100K at a wavelength of 0.9334A ˚ and processed using
Mosﬂm (26) and Scala (27). Crystals belong to space
group P3221 with cell dimensions: a=b=76.4A ˚ ,
c=80.4A ˚ ,  = =90  ,   =120 .
Selenomethionine labelled crystals diffracted to 1.9A ˚ at
Diamond, UK, on beamline I03 at a temperature of 100K
and a SAD data set at a wavelength of 0.9764A ˚ was col-
lected. The data were processed using Mosﬂm (26) and
Scala (27). Spd1 Se-Met crystals are isomorphous with
the native crystals, with cell dimensions a=b=80.4A ˚ ,
c=78.9A ˚ ,  = =90  ,   =120 . The unit cell volume
indicates one molecule in the asymmetric unit, with a
solvent content of 53%.
Using both the native and SAD data, four selenium
sites were found by SHELXD embedded in the
AUTOSHARP pipeline (28), which was also used to
perform phase calculations and density modiﬁcation.
The resulting phases were of sufﬁcient quality for ARP/
wARP (29) to build nearly all of the model. The model
was reﬁned by subsequent cycles of model building and
reﬁnement in COOT (30) and REFMAC5 (31).
Data for the Spd1 Asn145Ala mutant were collected
using a Rigaku Micromax-007HF generator equipped
with Osmic multilayer optics and a MAR345 imaging
plate detector to 2.5A ˚ resolution. Data were processed
using Mosﬂm (26) and reduced in Scala (27). Crystals
belong to space group P212121 with cell dimensions
a=49.8A ˚ , b=101.8A ˚ , c=113.5A ˚ ,  = =  =90  .
The structure was solved by molecular replacement with
Phaser (32) using the coordinates of the WT structure as a
search model. The solvent model was built in ARPWARP
(29). The model was corrected manually in COOT (30)
and reﬁned further in REFMAC5 (31). The structures
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(34). The crystal diffraction data and reﬁnement statistics
are presented in Table 1. The coordinates and structure
factors were deposited at the Protein Data Bank in Europe
(http://www.ebi.ac.uk/pdbe/), the structure validation can
be seen in Supplementary Table S3. Structure ﬁgures were
drawn with PyMOL (35) and CCP4mg (36).
DNase activity assays
Protocols for nuclease activity experiments were adapted
from Broudy et al. (8) and Aziz et al. (37). DNase activity
was assayed by incubating 1mg of calf thymus DNA,
plasmid DNA and RNA in 100mM Tris/HCl
pH 7.0–8.0, 1mM CaCl2 and 1mM MgCl2 with 0.35mg
of Spd1 and Spd1 mutants at 37 C for 45min. The
reaction was stopped by addition of 20mM ethylenedia-
minetetraacetic acid (EDTA). Duplicates of each reaction
with 20mM EDTA were used as negative controls as was
a cell-free extract produced from an ‘empty’ LIC expres-
sion construct. DNA degradation was visualized on 1.2%
agarose gel.
Sequence alignment
Sequence alignments of available structural homologues
were performed using the Multialign program (38).
Size-exclusion chromatography with multi-angle light
scattering
About 100ml of WT Spd1, Spd1 Asn145Ala and Spd1
Glu164Ala at concentration of 0.5mgml
 1 samples were
injected and separated on a BioSep-SEC-S 3000 column
(Phenomenex) equilibrated in 25mM Tris pH 8.0, 150mM
NaCl at room temperature, at 1ml/min. To determine the
effect of Mg
2+ ion concentration on the quaternary struc-
ture of WT Spd1, gel ﬁltration buffers were prepared con-
taining 150mM NaCl with the addition of 0, 2 and 50mM
MgCl2. A control buffer where the MgCl2 was replaced by
10mM EDTA was also included in order to chelate trace
metal ions. Light scattering data were recorded on an
in-line Dawn Heleos II 18-angle light scattering detector
with an in-line Optilab rEX refractive index monitor (both
from Wyatt Technology). Data were analysed by ASTRA
software and ﬁtted to the Zimm model with an estimated
dn/dc value of 0.183ml/g (39).
Determination of haplotonic or diplotonic mechanism
Analysis of plasmid DNA states during cleavage by Spd1
at a concentration of 0.01mgml
 1 in 20mM HEPES at
pH 7.4, 5mM MgCl2 and 1mg of pUC19 plasmid DNA;
20ml aliquots were taken from the reaction mixture at the
indicated time points, and the reaction stopped by the
addition of DNA to the loading buffer. Digested
products were analysed by electrophoresis in 1% agarose
gel, and stained with SYBR Safe (Invitrogen) after
running. Untreated control (reaction mixture before the
addition of enzyme) and EcoRI linearized pUC19 were
included.
Continuous assays
DNase activity was assayed by a continuous method
based on the differential ﬂuorescence output of a DNA
dye called PicoGreen (Invitrogen) as described by Tolun
et al. (40)
Table 1. Spd1 and Asn145Ala mutant crystallographic data collection and reﬁnement statistics. Values in parentheses are for the outer shell
Native SeMet Asn145Ala
Data processing
Space group P3221 P3221 P212121
Unit cell dimensions (A ˚ ) a=76.4, b=76.4, c=80.4 a=77.1, b=77.1, c=80.9 a=49.8, b=101.8, c=113.5
Unit cell angles ( ) a=b=90, g=120 a=b=90, g=120 a=b=g=90
Molecules in AU 1 2
Wavelength 0.93400 0.97640 1.54179
Resolution range (outer shell) 51.10–1.70 (1.79–1.70) 66.81–1.88 (1.95–1.88) 50.92–2.48 (2.61–2.48)
Rmerge 0.090 (0.461) 0.076 (0.34) 0.056 (0.300)
<I/sI> 19.8 (5.3) 37.9 (6.9) 17.5 (4.5)
Completeness 100 (100) 99.9 (98.6) 90.3 (82.5)
Redundancy 10.7 (10.8) 17.4 (14.0) 3.9 (3.6)
Reﬁnement statistics
Resolution range (A ˚ ) 38.21–1.70 (1.74–1.70) 50.92–2.48 (2.55–2.48)
Rcryst 0.168 0.166
Rfree 0.208 0.244
No. protein atoms 1668 2993
RMSD bonds (A ˚ ) 0.018 0.019
RMSD angles ( ) 1.782 1.831
Mean B-value protein atoms (A ˚ 2)1 4 3 7
Mean B-value solvent atoms (A ˚ 2)2 9 3 9
ESU (A ˚ 2) 1.686 6.637
Ramachandran statistics
Preferred regions (%) 98.86 93.12
Allowed regions (%) 1.14 5.44
Outliers (%) 0 1.43
PDB code 2XGR 2XH3
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The plasmid vector pUC19 was linearized with EcoRI
(Fermentas) and used as a homogeneous substrate for
the continuous assay. The linearization was veriﬁed by
agarose gel electrophoresis, and the restriction endonucle-
ase inactivated in accordance with the manufacturer’s in-
structions (heat denaturation at 65 C for 20min).
Measurement of ﬂuorescence
Fluorometer measurements were taken using a
Fluoromax-4 spectroﬂuorometer set to the following par-
ameters: excitation wavelength, 484nm; emission wave-
length, 522nm; slit width (all slits), 2nm; data sampling
frequency, 1s±1; assay period, 600s. Reaction condi-
tions: all reactions were carried out at the temperature
inside the spectroﬂuorometer of 25 C. Reaction mixtures
(0.5ml) contained 20mM HEPES pH 7.4, 5mM MgCl2
and linearized pUc19 at a concentration of 400ng/ml.
PicoGreen (Invitrogen) was diluted in the reaction
buffer and added to the mixture at a dilution of 1:2000.
The reaction mixture was placed in a Quartz cuvette and
incubated in the spectroﬂuorometer with continuous
stirring for 5min without light. The data collection was
started and the reaction indicated by the addition of 10ml
enzyme after 100s. The Spd1 concentration was adjusted
by a series of two dilutions and tested at 2.5, 1.25 and
0.620mg/ml. DNase I (from bovine pancreas, Sigma cat.
no. D56K7680) was used as a positive control at a con-
centration of 1mg/ml. As a negative control Spd1 at a
concentration of 2.5mgml
 1 was assayed in the presence
of 5mM EDTA.
Chemical cross linking reactions
Crosslinking reactions were carried out using Dimethyl
adipimidate (DMA) and Dimethyl suberimidate
(DMS).To determine the possible effect of combinations
of Mg
2+, NaCl and EDTA on the multimeric nature of
WT Spd1, cross-linking experiments were performed.
DMA and DMS stock solutions were freshly prepared
at a concentration of 6mgml
 1 and the pH was
adjusted to 8.5 using NaOH. The reaction was carried
out in a volume of 250ml in 20mM HEPES buffer (pH
7.4) with DMA and DMS at a ﬁnal concentration of
1.5mgml
 1 with a WT Spd1 protein concentration of
0.5mgml
 1. Varying combinations of MgCl2, NaCl and
EDTA were tested in a matrix over the following concen-
tration ranges: MgCl2 0, 5, 10 and 50mM, NaCl 0, 50,
150, 500mM and EDTA 10mM. The cross-linking reac-
tions were incubated for 3h at room temperature and then
stopped by the addition of SDS denaturing sample buffer.
Samples were analysed using SDS–PAGE with a 12% gel.
RESULTS
Gene cloning and expression
The expression of the catalytically active WT Spd1 DNase
was achieved in E. coli. Cellular toxicity was not found to
be problem as in previous studies (23,41). The expression
construct incorporated the streptococcal secretion signal,
which was cleaved by E. coli during expression, this was
conﬁrmed by electrospray mass spectrometry.
Spd1 structure determination
The WT Spd1 structure was solved by conducting a SAD
experiment using the data shown in Table 1. The WT Spd1
sequence was modelled from residue Arg33 to Pro250 out
of the 223 residues expected after the cleavage of the signal
peptide between Ala29 and Arg30, according to the
SignalP server (42). The region from residue Asn94 to
Ser114 is disordered and there is no interpretable
electron density for these residues. There are eight poly-
ethylene glycol side chains modelled in the structure. The
ﬁnal crystallographic R factors for all reﬂections are 20%
(Rfree) and 16.8% (Rcryst).
The Spd1 Asn145Ala inactive mutant crystallized in a
different (P212121) space group from the WT Spd1. The
structure was reﬁned to crystallographic R factors of 16%
(Rcryst) and 24% (Rfree) and built at a resolution of 2.5A ˚
with two molecules in the asymmetric unit. A larger pro-
portion of the Spd1 Asn145Ala structure is disordered
than of the WT structure. The model was built from
Thr48 to Asn252 out of 253 residues. Residues from
Lys87 to Lys112 are also missing from the density.
Structure characteristics
Spd1 displays a mixed a/b-fold, with 12 b-strands and 2
a-helices. Figure 1a shows the constituent secondary struc-
ture of the Sdp1 protein. A series of b sheets run
anti-parallel around the main a2 helix (green to yellow).
These are b2–b3 (light blue to turquoise) b6–b7 (yellow to
orange) b10–b9 (orange to light red). The N- terminal b1
and b8 (deep blue and light red) lie toward one end of the
main a2 helix. The b-sheets 4 and 5 (green) lie adjacent to
the smaller a1 helix; these motifs would harbour resi-
dues involved in metal ion coordination and catalysis.
Figure 1b shows the position of the active site histidine
(red). The DNA binding region can be seen as a major
groove sculpted within the structure (Figure 1b.) The di-
mensions of the cavity are  13 11 8A ˚ .
Nuclease activity
WT Spd1 was shown to degrade both single- and
double-stranded DNA as well as RNA. When puriﬁed
samples of Spd1 were assayed in the presence of calf
thymus DNA and RNA and run on agarose gels, a
complete degradation of the nucleic acid was observed
after 45min of incubation. The nuclease activity was
also assessed by the measurement of absorbance at
260nm. In this case, the complete degradation of the
sample was observed during a time course of 40min
after the addition of enzyme, Figure 2. The digestion ex-
periments were carried out in the presence of magnesium
and calcium ions as well as in the presence of EDTA. We
observed that the presence of metal is crucial for activity
and ion chelation by the EDTA completely inhibited the
reaction.
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mutants. Arg90Ala, His121Ala, His121Asp, His121Asn,
Asn145Ala, Asn145Gln and Glu164Ala substitutions
inactivated the Spd1 nuclease. The Asp88Ala, Lys92Ala,
Asn118Ala, Arg119Ala, Gln126Ala, Met140Ala and
Asn165Ala mutants were found to be catalytically active
Figure 2.
Continuous assay
WT Spd1 was assayed by continuous means (Figure 3) on
a linearized pUc19 substrate together with a EDTA and
DNase I control. Activity is indicated by a decrease in
ﬂuorescence, due to the dissociation of PicoGreen dye
when the DNA is digested. A decrease in ﬂuorescence
was observed for all three dilutions of the WT Spd1 and
the positive control indicating activity. This activity was
inhibited at the highest enzyme concentration of WT Spd1
by the inclusion of 5mM EDTA in the reaction buffer.
Size-exclusion chromatography with multi-angle light
scattering
To determine the oligomeric state of Spd1 and Spd1 active
site mutants in solution (25mM Tris pH 8.0)
size-exclusion chromatography with multi-angle light scat-
tering (SEC-MALLS) experiments were carried out.
Molecular weights were calculated by ASTRA software
(Wyatt Technologies) by splitting the chromatogram
into two ‘slices’. The ﬁrst slice covers the maximum of
the peak (Peak 1) and the second one covers the whole
chromatogram peak (Peak 2). Average molecular weights
were calculated for each ‘slice’ separately. The average
calculated molecular weights for the native Spd1, Spd1
Glu164Ala, Spd1 Asn145Ala, in the presence and
absence of MgCl2 and 10mM EDTA are in the range of
24–28kDa, suggesting that Spd1 exists as a monomer in
the solution, as the estimated mass of Spd1 is 28kDa
(Supplementary Table S2).
Determination of haplotonic or diplotonic mechanism
To determine whether the enzyme operates via a
haplotonic or diplotonic mechanism (induces a single- or
double-strand break in DNA), we performed a timed
assay on plasmid DNA (pUc19) using a dilute preparation
of Spd1. It can be seen (Figure 4) that the digestion of
plasmid DNA proceeds via a single strand nick, mediating
relaxation of supercoiled DNA. This can be seen to
emerge 30s to 1min into the reaction, within the same
time frame a linear form of the vector also emerges as
both species occur simultaneously. This points to a more
complex mechanism as observed in enzymes such as
bovine DNase I (43). This digestion has been shown to
pass through three phases, (i) relaxation of the plasmid
(ii), partial linearization of the relaxed plasmid and
(iii) plasmid degradation and the formation of
low-molecular weight products (43).
Spd1 cross-linking
The effects of MgCl2, NaCl and EDTA on WT Spd1 were
assessed in a combination matrix in the presence of the
cross-linking reagents Dimethyl suberimidate and
Dimethyl adipimidate. On analysis of the SDS–PAGE
gels (results not shown) it was found that no cross-linking
was observed in any of the conditions tested, with the
protein band corresponding to 25kDa, consistent with
the size of the monomeric Spd1 protein.
DISCUSSION
Quaternary structural characteristics
The family of bba/metal-dependent nucleases contain
enzymes showing both monomeric and dimeric quater-
nary structures. Using light scattering and structural
studies Miller and Krause (44) showed the Serratia
nuclease (PDB code 1SMN) to be a homodimer
composed of two polypeptide chains linked through the
C-terminal sub domain by a series of hydrogen bonds and
salt links at the dimer interface. The two active site regions
are accessible by substrate and are located on opposite
Figure 1. (a) Colour ramped N- to C-terminal (ramped blue to red)
cartoon representation showing the secondary structure of Spd1. The
following colours correspond to the secondary structure features in the
text b1–b2 deep to light blue, b3–b5 turquoise to green, a1–a2 green to
yellow, b6–b8 yellow to orange and b9–b12 light red to deep red. (b)
Modelled surface of the WT Spd1 structure in the same orientation as
(a), showing the position of the catalytic histidine His121 (red).
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combination of point mutagenesis and chemical
cross-linking at the dimer interface Franke et al. (45)
were able to produce and assay monomeric and dimeric
forms of the Serratia nuclease and these were compared to
the monomeric Anabaena nuclease. This study concluded
that dimerization is required for the processive degrad-
ation of nucleic acids, but not for the diplotonic
(double-stranded) cleave of DNA (45).
The Spd1 WT protein crystallized in a dimeric form,
through a series of interactions made by a loop Lys 87–
Lys 92, which protrudes into the active site cleft
(Figure 5). This dimerization is unlike the Serratia
nuclease, as interactions are made between different
areas of the protein. In addition to this the active site is
blocked by Arg 90 from an adjacent symmetry related
molecule (Figure 5). This residue appears to have
occupied the site associated with the active site metal
ion. This has resulted in a ‘self inhibiting’ dimer and
shows a structural resemblance to the Nuclease
A-Inhibitor Complex (46). To investigate this further
and rule out the possibility of a naturally occurring self
inhibiting dimeric form of the protein we submitted the
model to the PISA Interfaces analysis http://www.ebi.ac
.uk/msd-srv/prot_int/pistart.html. This resulted in a
Figure 2. Spd1 and Spd1 mutants assayed in the presence and absence of EDTA; visualized on 1.2% agarose gel. A LIC control has been included
to account for ‘background DNAse activity’ (see ‘Experimental Procedures’ section) and H2O as a negative control.
Figure 4. Observation of the pUC19 plasmid DNA states during
cleavage by Spd1. Aliquots were taken from the reaction mixture at
the indicated time points, and digested products were analysed by elec-
trophoresis in 1% agarose gel, staining with SYBR Safe (Invitrogen).
Control lanes 1: Hyperladder I (Bioline); Lane 2: Untreated pUC19;
Lane 3: EcoRI linearized pUC19; Lane 4: Reaction mixture prior to the
addition of Spd1. The digestion of plasmid DNA proceeds via
single-strand nick mediated relaxation of supercoiled DNA, this can
be seen 30s to 1min into the reaction; within the same time frame a
linear form can also be seen emerging.
Figure 3. The activity of Spd1 on 400ng/ml linearized pUC19 sub-
strate. Activity can be monitored by a decrease in ﬂuorescence due to
the dissociation of PicoGreen dye when the DNA is digested. WT
Spd1 was tested over a series of 2-fold dilutions. DNase I was used
as a positive control. The inclusion of EDTA at a ﬁnal concentration of
0.5mM inhibited 2.5mgml
 1 WT Spd1.
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this observation is not a crystallographic artefact. To
observe the multimeric nature of Spd1 in solution, we per-
formed a series of SEC-MALLS experiments over a
range of Mg
2+ ion concentrations and in EDTA (see
Supplementary Data).
These results indicated that the WT Spd1 protein is
monomeric in solution irrespective of the presence of
EDTA or Mg
2+ ions. We have shown the WT Spd1 to
be active in solution (Figure 3), and this activity to be
dependent on the presence of Mg
2+. Our Spd1 WT
dimeric structure is devoid of metal ions and so cannot
be the active species we observe in our activity assays. This
does not rule out the possibility of Spd1 dimerizing in
another way, perhaps on association with DNA. We
have observed that Spd1 is able to cleave plasmid DNA
through relaxed and linear intermediates (Figure 4) similar
to DNaseI (43). Production of the linear form could
involve either the sequential presentation of each strand
of DNA to a monomeric enzyme or a dimeric enzyme
orientated to cleave both DNA strands simultaneously.
Our cross-linking studies are consistent with a monomeric
enzyme, but proved inconclusive as we were unable to
cross-link WT Spd1 under the conditions tested. This
does not prove that Spd1 is active as a monomer, given
that a dimer that is unable to cross-link would also give
this result.
The structure of the Asn145Ala mutant shows an active
site free from symmetry-related molecules. The effect of
mutation appears to have disrupted metal ion coordin-
ation, leaving this structure again devoid of an active
site metal ion. This is consistent with the proposed role
of the active site Asn in other characterized DNases (47).
Our activity assays have indicated this residue is required
for the maintenance of activity.
Comparison with other nucleases
The closest structural homologues related to Spd1 are
EndA from S. pneumoniae, with a Z-score of 7.8 and
rmsd of 1.8A ˚ , based on SSM server search (48) (PDB
code 3OWV), followed by NucA from Anabaena sp.
(Z-score 6.4, rmsd of 2.1A ˚ , PDB code 1ZM8), Sm endo-
nuclease from S. marcenscens (Z-score of 5.8 and rmsd of
1.9A ˚ , PDB code 1QL0) and EndoG endonuclease
(Z-score of 5.6, rmsd of 2.3A ˚ , PDB code 3ISM).
Despite a low sequence similarity between these proteins,
there is strong conservation of the DRGH (Figure 7)
sequence motif; in the Spd1 sequence there is an
Asparagine (Asn119) instead of Aspartic acid (Figure 7).
The structural similarity between these nucleases is mostly
pronounced in the b-strands forming the central sheet and
in the bba-Me motif comprised of two short b-strands and
a long a-helix running along the central b-sheet. Further
away from the catalytic centre Spd1 and EndA share the
highest resemblance in their secondary architectures
(Figure 6). They both contain a small C-terminal b-sheet
composed of two anti-parallel strands, which are situated
on the top of the central core of the structure. The dis-
ordered loop of Spd1 (from Asn94 to Ser114) corresponds
to the missing region in EndA (Tyr124 to Ser136). The
proximity of this loop to the putative DNA binding site
and mutagenesis studies in EndA suggest the residues
located in this region may synergistically bind the DNA.
Another feature characteristic to Spd1 and EndA is the
‘ﬁnger-loop’ interruption of the long a-helix that is not
observed in any other described nuclease structure. The
active site architecture of all bba-Me nucleases is very
similar. Bound metal ions identiﬁed in described structures
are Mg
2+ in EndoA, Serratia, I-PpoI, Vvn and nucleases,
Ca
2+ in T4 endo VII and Mn
2+ in NucA and I-HmuI
nucleases. In all of these structures, the metal ion is
hydrated by a cluster of neighbouring water molecules.
In the Spd1 structure, there are only two water molecules
in the proximity of Mg
2+. The side chain oxygen of
Asn145 is a direct ligand for the metal ion and is highly
conserved among bba-Me nucleases. A strong resem-
blance is also seen for the catalytic Histidine (His121 in
Spd1, His160 in EndA, His124 in NucA, His89 in Serratia,
His98 in I-PpoI, His80 in Vvn nuclease, His41 in T4 Endo
VII and H143 in mitochondrial EndoG). Glu164 that is
facing the magnesium ion, corresponds to Glu127 and
Glu163 in Serratia endonuclease and NucA, respectively,
and to Glu205 in EndA. These Glutamate residues are
involved in positioning two water molecules to interact
with the metal ion and form a metal cluster. This may
explain why mutating Glu164 in Spd1 has a detrimental
effect on nuclease activity, even though in the crystal
structure it is >6A ˚ away from the magnesium ion.
Arg61 in the I-PpoI structure interacts with the nucleotide
phosphate backbone. The same has been observed for the
corresponding Arg99 in Vvn nuclease. Equivalent residues
in NucA and Serratia are Arg93 and Arg57, respectively.
In the Spd1 structure, the corresponding Arg90 is ﬂipped
180  and points outside. Gln150 in NucA positions the
neighbouring water molecule to interact with Mn
2+.I t
corresponds to Gln114 in Serratia nuclease, Gln186 in
EndA, Glu114 in I-PpoI and 79 in Vvn nuclease. Spd1 is
the only structure with a Methionine in this position
(Met140).
Figure 5. The Spd1 WT protein shown in dimeric form, a series of
interactions made by Lys 87–Lys 92, which protrudes blocking the
active site cleft. Arg90 (ball and stick representation) has displaced
the active site metal ion. The A molecule is shown in teal blue and
the B molecule in salmon pink.
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DNA Binding. The crystal structure of Spd1 reveals a
bba-metal ﬁnger motif, which is comprised of b-sheets 4
and 5 (green, Figure 1a), which lie adjacent to the smaller
a1 helix. These motifs harbour residues involved in metal
ion coordination and catalysis. Mutagenic studies and
structure comparisons with other published nucleases
allowed us to identify catalytically important residues. It
has been shown before that an active site His (His121
equivalent) is crucial for S. pyogenes nuclease activity
(49). Mutations His121Ala and His121Asp abrogate
Spd1 activity (Figure 2). In the Spd1 structure, His121 is
located at the C-terminus of strand b5 (Figure 8). The
main-chain oxygen of Leu130 makes a hydrogen bond
with the other imidazole nitrogen of His121 (2.9A ˚
distance), suggesting this residue is deprotonated in the
structure. On the opposite side, in the helical motif,
there is Asn145 that is likely to coordinate the active site
metal ion directly through its side-chain oxygen atom.
Mutations of this residue to Ala and Gln curtailed Spd1
activity (Figure 2). Glu164 is crucial for activity, even
though it is 6.7A ˚ away from active centre and does not
make direct contacts in the active site environment.
Proposed reaction mechanism. Similarities between the
active sites of the discussed nucleases and high conserva-
tion of the bba-Me motif suggest that Spd1 may use the
same mechanism for DNA hydrolysis. We propose that
His121 would act as a general base, removing a proton
Figure 7. Protein sequence alignment showing Spd1 in comparison to its closest known structural homologues: S. pyogenes nuclease (Spd1), pdb
code 2xgr; S. pneumoniae nuclease (EndA), pdb code 3owv; Anabaena sp. nuclease (NucA), pdb code 1zm8; Drosophila melanogaster nuclease
(EndoG), pdb code 3ism; Serratia marcescens nuclease (smn), pdb code 1smn. Secondary structure elements are taken from the Spd1 structure
and indicated by the following, b-beta strand; a-alpha helix; TT-beta-turn; Z-310 helix; grey star-residues modelled with an alternate conformation.
Conserved residues are shown highlighted in red; areas of high homology are boxed in blue. Note Spd1 shows a variant asparagine residue at
position 118, resulting in a NRGH catalytic motif, which was previously considered to be a conserved DRGH motif.
Figure 6. WT Spd1 overlaid with EndA from S. pneumoniae (PDB
code 3OWV) showing the structural similarity between the nucleases.
Notable structures are the b-strands forming the central sheet, the
bba-Me motif comprised of two short b-strands and a long a-helix
running along the central b-sheet.
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attack the scissile phosphodiester bond (Figure 9). The
divalent magnesium ion would act as a Lewis acid pos-
itioning the water molecule to donate a proton to a de-
parting 30-oxygen. Arg90 would change its position and
orient in the direction of cleaved 50-phosphate to make a
hydrogen bond, as has been shown to occur in the Vvn–
DNA complex and in the I-PpoI structures. This would
stabilize the product in order to prevent the reverse
reaction (20). The role of Asn145 and Glu164 in
coordinating the essential metal ion (Glu164 indirectly
through a water molecule) agrees with the mutagenesis
experiments that prove the crucial role of these residues,
as Asn145Ala, Asn145Gln and Glu164Ala mutants
appear to diminish Spd1 activity.
The biological role of Spd1. The precise biological role of
Spd1 in S. pyogenes SF370 and the SF370.1 prophage/
phage is not fully understood. At the point of prophage
induction, there exists a three way interplay between the
phage, the bacterium and the human host. The
phage-mediated acquisition of both toxin and DNase
genes as a factor enhancing virulence appears to be a
common theme, and it is tempting to speculate that their
co-expression is evolutionarily advantageous by synergis-
tically acting against the immune system to promote
survival of the phage and bacterium. It has been suggested
that phage-encoded streptococcal DNases may promote
the survival of the phage by liquefying pus and cellular
material to reduce viscosity and aid bacterial and phage
particle dissemination (8). This idea may be extended and
it is proposed that the occurrence of the toxin and DNase
genes may give the phage and bacterium (prophage) a se-
lective advantage by avoiding clearance by the NETs.
There is some evidence that the expression of
phage-encoded DNase extends beyond the Streptococcus
genus. A BLAST search using Spd1 (http://blast.ncbi.nlm.
nih.gov/Blast.cgi) reveals that Pro-phage homologues can
be found in the lactobacillus genus exempliﬁed by a homo-
logue from Lactococcus lactis sharing a 46.25% identity to
Spd1 (8,9). This indicates that phage-encoded DNases
enhance the survival of the phage in an environment
that is not normally associated with the human immune
system and so points to broader evolutionary mechanism
beyond the host pathogen interaction.
In this study, we have described a method for the
cloning, expression and puriﬁcation of a DNase from
S. pyogenes in WT and mutant forms. We have gone on
to present its X-ray structure, shown the location of key
active site residues and that His121, Asn45 and Glu164,
are essential in maintaining activity. Our work has shown
two crystal forms, a WT catalytically blocked dimer and a
monomeric Asn145Ala mutant. The results from the SEC-
MALLS experiments show that Spd1 behaves as a
monomer in solution in the presence and absence of the
divalent metal ion Mg
2+. The digestion of plasmid DNA
Figure 8. Stereo representation of the WT Spd1 active site showing the positions of the key active site constituents (the Arg90 from the symmetry
molecule has been removed for clarity): Waters 2074, 2076, 2076 and polyethylene glycol and residues Asn118, Arg119, His121, Val123, Leu130,
Met140 and Asn145.
Figure 9. Schematic diagram of the proposed mechanism of Spd1.
His121 acts as a general base, removing a proton from a neighbouring
water molecule; this attacks the scissile nucleotide phosphate. The
divalent metal ion acts as a Lewis acid stabilizing the negative charge
on the nucleotide phosphate transition state and the leaving group. The
metal ion is coordinated by the side-chain oxygen of a conserved
Asparagine (Asn145) and a Glutamic acid (Glu164). Arginine 90 is
involved in positioning the substrate around the cleavage point.
936 Nucleic Acids Research, 2012,Vol. 40,No. 2shows three distinct phases, (i) relaxation (ii), partial lin-
earization and (iii) plasmid degradation. This triphasic di-
gestion pattern points to an underlying complex substrate
interaction at a molecular level. Due to the role of strepto-
coccal DNases in disease progression, these proteins rep-
resent a target for inhibition. The provision of these
structures and data will be of interest to those wishing
to perform future mechanistic studies and epitope
mapping to aid vaccination design.
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